Pharmaron Health Corporation (02617.HK) intends to conduct share buybacks on the market based on the general authorization.

Zhixin Financial APP News, Sanai Health-B (02617.HK) announced that, in accordance with the general authorization to repurchase H shares approved by the shareholders of the Company at the Company's annual general meeting held on June 18, 2026, the Company intends to repurchase its H shares from time to time on the open market, with a total amount not exceeding RMB 100 million or its equivalent in Hong Kong dollars. The repurchase of shares will be funded in accordance with applicable laws and regulations. The repurchase period will commence from the date of the aforementioned annual general meeting of shareholders and will expire on the earliest of the following dates: (1) the end of the next annual general meeting of the Company; (2) the expiration of the period specified in the Company's articles of association or any applicable laws requiring the Company to convene the next annual general meeting of shareholders; and (3) the date on which the shareholders revoke or amend the authorization contained in the resolution of the aforementioned annual general meeting of shareholders.